Techno Drugs Limited’s private company primarily focuses on specialized products, offering a range of products in Oncology, Anesthesia, Birth Control Pills, Injections, and modern technology Implant sticks (for 5-year birth control). The company was registered as a private company in 2009 and converted into a public company in 2019. Additionally providing veterinary and general human medicines.
Their main medicines include:
Birth Control Medicines: Sukhi 3rd Generation oral pill, Provera Injection, Implant Stick 5 years birth control
Anti-cancer Medicines: Hertin, Zolomide, Eposide
Anesthesia Medicines: Lidocaine plus Inj, Vencuron-10 IV Inj
General Human Medicines: Motilex Suspension, Omsec, Romilac, Cefixon Injection.
Veterinary Medicines: Vermic Inj, Dexavet Inj, Rumen plus pow, Vitazinc Sol
Techno Drugs Limited has been advancing in producing and distributing high-quality medicines. The company’s management director, Mehereen Ahmed, holds a PhD in Oncology from Dhaka University, ensuring expertise in the field. The management team and staff work diligently to ensure quality.
Every year, Techno Drugs Limited supplies the highest amount of birth control medicines in opposition to tenders from the Family Planning Directorate of the Bangladesh Government. With 17 depots across the country, they ensure nationwide distribution. The company also has a “24/7 Monitoring Team” at every level to ensure proper monitoring of all company operations.
With listing on the stock market, Techno Drugs Limited anticipates increased production and sales, benefiting investors and stockholders. Their commitment to corporate governance, job creation, business expansion through IPO funds, and regular dividends to investors aims at socio-economic development in the country and enhancing the country’s reputation in the global pharmaceutical market.
Techno Drugs continues to produce life-saving medicines and is progressing as a profitable company. With various specialized products and a wide range of human and veterinary medicines, they aim for further advancement in the future. Currently, the company’s total capital is approximately 94 crores taka with management holding 63% and the management board having 88% of the shares. Techno Drugs believes that with their capable management and dedicated staff, they will achieve more success in the future, making it a secure investment for investors.
